Despite a 5.7 percent increase in sales to $1,192 million...

Despite a 5.7 percent increase in sales to $1,192 million in the third quarter, Allergan reported a net loss of $670.5 million compared with profits of $239.2 million last year. The overall sales increase was 6.3 percent on a currency-neutral basis. Revenues from eye care pharmaceuticals grew by 6.3 percent ...

To continue reading this article subscribe now

Already an Eyewear Intelligence subscriber? Sign in here.


Become a member today for full access from just €6,70 a week!

Buying a membership today will give you:

  • Unlimited access to - all insight and analysis available online
  • Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
  • Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
  • Case studies and best practices on business challenges
  • Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
  • Access to over 11,500 articles and analyses in the archive
  • Personal library to save articles and track your key content
  • Powerful search and intuitive navigation

Or sign-up for a trial month for just 9,90€. To continue reading this article register now.